The short version: all three of these products are built the same way. A genuine, well-dosed multivitamin sits at the front of the label. Behind it sits a long tail of greens, botanicals, mushrooms and adaptogens, most of them present in single- or double-digit milligrams — a fraction of the dose used in the trials those ingredients are famous for. You are paying $120–170 a month for a good multivitamin, a real dose of two or three actives, and a very long ingredient list.

That is not a scandal. It is how the category works, and once you can read the label you can decide whether it is worth it to you. This page is the label-reading.

No affiliate links on this page. Nothing here earns MyKine a commission. Prices are listed so you can do the arithmetic yourself.


What each one actually is

AG1 (Next Gen)IM8 Daily Ultimate EssentialsTMRW
Serving13 g11.8 g (original) / 13.6–14.4 g (Pro)10.3 g
Ingredients claimed75+90–9288–90
PositioningFoundational nutritionAll-in-one essentials"Clinically dosed" longevity
Launched2010 (Next Gen: May 2025)Nov 202422 Sep 2026
Behind itAG1 Inc. (formerly Athletic Greens)Prenetics Global (Nasdaq: PRE), with David Beckham as co-founding partnerAnthony Baxter & Stuart Vaughan (previously Simply Nootropics)
Made inNot publicly disclosedNot publicly disclosedNew Zealand
Label transparency~30 line items disclosed; ~42 ingredients pooled into two blendsVitamins/minerals disclosed; six named "complexes" with totals only32 line items disclosed; ~50 ingredients pooled into six blends
AU price/servingA$4.97 monthly, A$3.66 quarterly (ex shipping)~A$3.00 quarterly (converted from USD; AU shipping not free)A$4.30 monthly, A$3.98 on 60/90-day, A$5.73 one-off (free AU shipping)
Vitamin DNone1200 IU (orig) / 2000 IU (Pro)1000 IU
IodineNone150 mcgPresent, amount not disclosed
Iron1 mg (token)NoneNone

Three things jump out before you read a single ingredient.

AG1 has no vitamin D and no iodine. For a product sold as foundational daily nutrition to an Australian audience, those are the two most defensible things you could put in a tub, and they are the two that are missing. Vitamin D deficiency is common through an Australian winter, particularly south of Sydney. Iodine is why Australia mandated iodised salt in bread in 2009.

TMRW markets on "no proprietary blends" and has six of them. Its panel discloses 32 line items properly — and then pools roughly fifty more ingredients into six category blends with nothing but a total weight each: Superfoods & Botanicals ~995 mg (19 ingredients), Longevity Activation ~969 mg (9), Gut Health ~855 mg, Cellular Electrolytes & Minerals ~732 mg, Skin/Hair/Joint ~315 mg (4), Liver & Detox ~315 mg (4). That is about 4.3 grams of a 10.3 gram scoop with no individual amounts. Calcium, copper, iodine, selenium, manganese and boron are all in there, present but unquantified.

To be fair to TMRW: its disclosed portion is genuinely more informative than IM8's, and it quantifies two things IM8 buries — alpha-lipoic acid at 100 mg and choline at 220 mg. But a claim of no proprietary blends, on a label with six of them, is the kind of thing worth noticing.

There are two different IM8 formulas in market. The original and the "Pro" differ materially — B12 24 mcg vs 200 mcg, vitamin D 1200 IU vs 2000 IU, K2 40 vs 100 mcg, magnesium 65 vs 100 mg. Both sets of figures above are taken from the US labels; check which formula you are buying, because the supplement facts panel differs by market as well as by version.


The shared core: vitamins and minerals

This is the part of all three products that is real. These are disclosed amounts, established nutrients, and mostly sensible forms. Percentages below are against the Australian NRV (RDI or AI, adults 19–50), not the US Daily Value printed on the tub — the two differ enough to matter, and vitamin C is the extreme case. If you are reading from outside Australia, the US Daily Value is the benchmark on your tub — it is generally the more permissive of the two, so a percentage that looks modest here will look smaller again against the US DV.

NutrientAG1IM8 ProTMRWAU RDI/AIAU Upper Limit
Vitamin C500 mg900 mg400 mg45 mgno AU UL (US 2000 mg)
Vitamin D3—50 mcg25 mcg5 mcg (AI)80 mcg
Vitamin A550 mcg RAE (beta-carotene)900 mcg (retinyl palmitate)500 mcg RAE (beta-carotene)900 M / 700 F mcg3000 mcg
Vitamin E20 mg15 mg30 mg10 M / 7 F mg (AI)300 mg
Vitamin K2 (MK-7)90 mcg100 mcg100 mcg——
Thiamin (B1)3 mg (+25 mg benfotiamine)4 mg15 mg1.2 M / 1.1 F mg—
Riboflavin (B2)2 mg4.2 mg (R-5-P)0.5 mg1.3 M / 1.1 F mg—
Niacin (B3)16 mg NE (part nicotinic acid)20 mg (niacinamide)none16 M / 14 F mg35 mg
Vitamin B65 mg (P5P)5 mg (P5P)2.5 mg (P5P)1.3 mg50 mg
Folate680 mcg DFE (5-MTHF)400 mcg DFE (5-MTHF)510 mcg DFE (5-MTHF)400 mcg DFE1000 mcg (folic acid)
Vitamin B12400 mcg200 mcg100 mcg2.4 mcg—
Biotin330 mcg300 mcgin a 315 mg blend30 M / 25 F mcg (AI)—
Pantothenic acid4 mg12 mg6 mg6 M / 4 F mg (AI)—
Zinc20 mg (citrate)15 mg (citrate)7.5 mg (bisglycinate)14 M / 8 F mg40 mg
Copper0.2 mg1 mgin a 732 mg blend1.7 M / 1.2 F mg (AI)10 mg
Magnesium30 mg100 mg (bisglycinate)24 mg (glycinate)400 M / 310 F mg—
Selenium22 mcg70 mcgin a 732 mg blend70 M / 60 F mcg400 mcg
Iodine—150 mcgin a 732 mg blend150 mcg1100 mcg
Chromium25 mcg100 mcg100 mcg35 M / 25 F mcg (AI)—
Calcium120 mg150 mgin a 732 mg blend1000 mg2500 mg
CoQ1060 mg (ubiquinone)100 mg150 mg (ubiquinone)——
Alpha-lipoic acid100 mgin a 1580 mg blend100 mg——
Choline25 mg55 mg220 mg550 M / 425 F mg (AI)3500 mg
Vitamin K1—30 mcg100 mcg70 M / 60 F mcg (AI)—
Potassium—470 mg100 mg3800 M / 2800 F mg (AI)—

All three sets of figures come from the manufacturers' own published supplement facts panels. TMRW's panel was verified on 1 October 2026 from the "View Supplement Facts" panel on its Australian product page. "In a blend" means the ingredient is present and named but its amount is not disclosed.

What's genuinely good here

All three use the better folate form, and that one is real. 5-MTHF versus folic acid is the single form claim in this category with solid pharmacokinetic support. In a crossover study (Obeid et al., Nutrients 2020;12(12):3623, n=24), 436 mcg of (6S)-5-MTHF gave an 8-hour AUC of 126.0 nmol/L·h against 56.0 for 400 mcg folic acid — roughly 2.25× the exposure and 3.3× the peak, p<0.0001. It also avoids unmetabolised folic acid circulating in plasma. Worth noting the flip side: AG1's 680 mcg DFE of a form absorbed two to three times better, against a 1000 mcg upper limit for folic acid, is not automatically a virtue.

IM8 is the only one with a coherent mineral profile. 150 mcg iodine at exactly the RDI, 70 mcg selenium at exactly the RDI, 1 mg copper alongside 15 mg zinc, 100 mg magnesium, 2000 IU vitamin D. Nothing heroic, nothing missing. If you want the tub to function as an actual multivitamin, IM8 Pro is the one that does it.

Australian selenium matters. Australian and New Zealand soils are selenium-poor relative to North America, so dietary intakes sit lower here. IM8's 70 mcg is well judged. AG1's 22 mcg is under a third of the RDI — present enough to list, not enough to do anything.

What's questionable

Vitamin B12 at 400 mcg is theatre. AG1's 400 mcg is roughly 167 times the Australian RDI. Absorption via intrinsic factor saturates at about 1.5–2 mcg per dose; everything beyond that crosses by passive diffusion at around 1%. So 400 mcg delivers perhaps 4–6 mcg absorbed. There is no upper limit for B12 and no established harm, but there is no benefit either — it exists so the tub can print a four-digit percentage. AG1's original formula had 22 mcg. The jump to 400 mcg came with Next Gen. IM8's 200 mcg and TMRW's 100 mcg are the same exercise at smaller scale.

AG1's zinc-to-copper ratio is 100:1. This is the most substantive safety criticism on this page, and it is the Australian regulator's own reasoning. The NHMRC set the zinc upper limit at 40 mg/day specifically because, in their words, the adverse effect of excess zinc on copper metabolism is the critical endpoint (LOAEL 60 mg, safety factor 1.5). Zinc induces intestinal metallothionein, which binds copper and prevents its absorption. AG1 pairs 20 mg of zinc — 250% of the female Australian RDI — with 0.2 mg of copper, about 12% of the AI. IM8's 15:1 is far more defensible, and TMRW's 7.5 mg of zinc bisglycinate — 68% of the US DV, just over half the Australian male RDI — is the most conservative of the three, with copper present (as copper citrate) though unquantified. On zinc, TMRW is the one that got it right.

To be fair about the strength of this: nobody has run a controlled trial of a 100:1 ratio at 20 mg zinc over years, so this is a plausible-mechanism concern rather than demonstrated harm. But it is the mechanism the upper limit is built on, and if you also eat oysters, take a zinc lozenge at the first sign of a cold, or stack another multivitamin, you clear 40 mg without noticing.

IM8's vitamin A is the preformed kind. 900 mcg of retinyl palmitate is 100% of the male RDI, daily, on top of whatever you eat, against an upper limit of 3000 mcg. Preformed retinol is the form implicated in the hip fracture and hepatotoxicity signals; beta-carotene, which AG1 uses, is converted on demand and cannot drive hypervitaminosis A. This one goes to AG1 — with the caveat that beta-carotene supplements increased lung cancer incidence in smokers and asbestos-exposed workers (CARET, Omenn et al. 1996; ATBC 1994), which is a reason for a warning line rather than a reason to avoid 550 mcg.

AG1's magnesium is 30 mg. That is about 7–9% of the Australian RDI. Every trial that shows magnesium doing something for sleep, blood pressure or cramps uses 300–500 mg. Thirty milligrams is a rounding error against the food supply. Whether it is dimagnesium malate or glycinate is beside the point. TMRW's 24 mg is worse. IM8's 100 mg is the only one in the game, and it is still sub-therapeutic.

CoQ10 is under-dosed in all three, and AG1's is also badly delivered. The trial everyone cites is Q-SYMBIO (Mortensen & Kumar, JACC Heart Fail 2014;2(6):641–9): 420 patients with NYHA class III–IV heart failure, 100 mg three times daily — 300 mg/day — for 106 weeks, with major adverse cardiovascular events at 15% versus 26% (p<0.005) and all-cause mortality 10% versus 18% (p=0.018). Note the population: symptomatic heart failure, not well people. AG1's 60 mg is a fifth of that dose, IM8's 100 mg a third, and TMRW's 150 mg — its entire "Heart Health Support" blend — exactly half. TMRW wins this one. CoQ10 is also highly lipophilic; a dry powder in water with no fat is close to worst case for absorption. The ubiquinol-versus-ubiquinone argument is largely marketing — formulation and co-ingested fat dominate the redox form.

Chromium, biotin, manganese, molybdenum and boron are label-filling. Human chromium deficiency is essentially not seen outside total parenteral nutrition, and the NIH Office of Dietary Supplements position is that supplementation has no established benefit in people without deficiency. IM8's 286% DV of chromium is decoration.

One practical note on biotin: at 300–330 mcg both AG1 and IM8 are around ten times the AI. High-dose biotin interferes with streptavidin-biotin immunoassays — troponin, thyroid function, some hormone panels — and the FDA issued a safety communication in 2017 after a death following a falsely low troponin result. But that case and most reported interference involve doses of 10–300 mg, hundreds of times higher. At 300 mcg, clinically significant interference is unlikely. Mention it to your pathologist; don't panic about it.

TMRW's B vitamins are strange in both directions. Thiamin at 15 mg is 1515% of the US DV and roughly twelve times the Australian RDI. There is no deficiency to correct and no trial at that dose supporting anything; it is simply a large number. Meanwhile riboflavin is 500 mcg — below the Australian RDI of 1.1–1.3 mg, and the only sub-RDI vitamin across all three products. And TMRW contains no niacin at all, which is an odd omission in a product built around NAD+ metabolism, since niacin is a direct NAD precursor and considerably cheaper than the NMN it sits beside.

Vitamin E is worth watching if you stack. TMRW's 30 mg is the highest of the three and roughly three to four times the Australian AI. For context, SELECT (Klein et al., JAMA 2011;306(14):1549–56) randomised 34,887 men to 400 IU/day of alpha-tocopheryl acetate and found prostate cancer incidence increased: HR 1.17 (99% CI 1.004–1.36, p=0.008). Thirty milligrams is a long way below 400 IU (~268 mg), so this is not a warning about TMRW specifically — it is the reason to not also take a vitamin E capsule on top.

Vitamin B6 and the TGA: the Australian detail nobody mentions

Australia has moved on B6 in a way most of the world has not, and if you take supplements here you should know the numbers.

  • Since 1 March 2022, any product supplying more than 10 mg/day of B6 must carry a warning statement about tingling, burning or numbness.
  • A final scheduling decision published November 2025, taking effect 1 June 2027, moves oral B6 above 50 mg/day to Pharmacist Only (Schedule 3), and above 200 mg/day to prescription (Schedule 4). Around 125 listed medicines are affected.
  • As at 31 October 2025 the TGA's database held 250 reports of neuropathy associated with B6-containing products.
  • The scheduling decision covers pyridoxine, pyridoxal and pyridoxamine alike. P5P is not a loophole — it is dephosphorylated at the gut wall and feeds the same pool. Any marketing that implies otherwise is wrong as a matter of Australian regulation.

Where these three sit: AG1 5 mg, IM8 5 mg, TMRW 2.5 mg. All comfortably under the 10 mg warning threshold. None of them triggers anything on its own.

The risk is stacking. Five milligrams from your greens powder, plus a magnesium-and-B-complex sleep formula, plus an energy drink, and you are over 10 mg with no warning statement on any individual product because no individual product needed one. That is the scenario worth watching, and it is the one the TGA itself flagged — consumers don't recognise B6 under its chemical names, and a 75-ingredient label is exactly where a chemical name hides.

Does a multivitamin do anything?

Worth being straight about, since that is what the front half of all three labels amounts to.

The evidence is mixed and the effect sizes are small. Physicians' Health Study II found a marginal reduction in total cancer over 11.2 years (Gaziano et al., JAMA 2012; n=14,641; HR 0.92, 95% CI 0.86–0.998, p=0.04) but a flat null for cardiovascular events (Sesso et al., JAMA 2012; HR 1.01, 0.91–1.10) and a flat null for cognition over 12 years (Grodstein et al., Ann Intern Med 2013;159:806–14; n=5,947; global composite difference −0.01 SU).

The COSMOS programme pushes the other way: pooled across three substudies totalling around 5,200 participants, daily Centrum Silver gave a global cognition improvement of +0.07 SD (95% CI 0.03–0.11, p=0.0009) (Vyas et al., Am J Clin Nutr 2024), which the authors frame as roughly two years of cognitive ageing. Note that the in-person clinic substudy's own primary outcome missed (+0.06 SD, −0.003 to 0.13).

And a large observational analysis found no mortality benefit at all: 390,124 adults, 164,762 deaths, up to 27 years of follow-up, daily multivitamin use versus non-use giving an all-cause mortality hazard ratio of 1.04 (1.02–1.07) in the first half of follow-up (Loftfield et al., JAMA Netw Open 2024;7(6):e2418729).

An 0.07 SD improvement on a cognitive composite, from a supermarket multivitamin, is the honest ceiling of what a greens powder could claim. It is not nothing. It is also not $150 a month.


The long tail: greens, botanicals, mushrooms

This is where the ingredient counts come from, and where the doses collapse.

AG1: 42 ingredients in 9 grams

AG1 Next Gen pools its plant material into two complexes:

Active Superfood and Prebiotic Complex — 7,500 mg across 21 ingredients, in descending order: organic apple powder, pea protein isolate, organic spirulina, lecithin, inulin, citrus bioflavonoids, organic chlorella, ginger root, cocoa bean, licorice root, bromelain, beta-glucan, artichoke 15:1, slippery elm, rhodiola 15:1, astragalus 4:1, cocoa seed extract, organic matcha, ashwagandha root 5:1, dandelion, eleuthero.

Daily Phytonutrient Complex — 1,500 mg across 21 ingredients: broccoli, papaya, beetroot, wheatgrass, alfalfa, barley leaf, carrot, acerola, rosehip, pineapple, shiitake, reishi, rutin, rosemary, bladderwrack, wolfberry, burdock, hawthorn, bilberry 100:1, milk thistle 70:1, grape seed 120:1.

Divide naively and you get 357 mg per ingredient in the first complex and 71 mg in the second. But the label tells you more than that. It declares 2 g of protein and 2 g of fibre. Essentially all the protein is the pea protein isolate, so that is 2.2–2.5 g on its own. Apple powder is listed ahead of pea protein, so it is at least that much again. Most of the fibre is inulin.

Apple, pea protein, spirulina, lecithin and inulin plausibly account for 6 to 6.5 of the 7.5 grams, leaving perhaps 1 to 1.5 grams for the other sixteen ingredients — an average near 60–95 mg. And descending order means ashwagandha, dandelion and eleuthero, sitting at positions 19, 20 and 21, are below that average.

(That bracketing is inference from the declared macros plus descending order, not a label figure. But it is the arithmetic the label makes available, and it is why descending order matters.)

IM8: the 200 mg complex

IM8 discloses six complexes. Two are genuinely well dosed: MSM at 1,500 mg and CoQ10 at 100 mg. The 4,100 mg superfoods complex holds the fruit and vegetable powders.

Then there is the Digestive Enzymes, Adaptogens & Super Mushrooms Complex — 200 mg total, containing reishi, chaga, rhodiola, ginseng, saffron extract, amylase, protease, cellulase and lipase. Saffron is separately disclosed at 30 mg, which is a real clinical dose (affron 28 mg/day, Lopresti et al., J Affect Disord 2018, n=68). That leaves 170 mg for the remaining eight ingredients — about 21 mg each.

Reishi's trial doses run 1,400–5,400 mg/day. Standardised Panax ginseng runs 200–400 mg. The arithmetic is not close.

TMRW: nine disclosed actives, seventy undisclosed

TMRW's panel does the arithmetic for you, and it checks out: named actives 4,375 mg, vitamins ~455 mg, itemised minerals ~182 mg, six blends 4,331 mg — about 9.3 grams of a 10.3 gram scoop, with citric acid, natural flavour and thaumatin accounting for the rest.

The blends are where it gets interesting:

BlendTotalIngredientsAverage
Superfoods, Botanicals, Adaptogens & Herbs~995 mg19~52 mg
Longevity Activation~969 mg9~108 mg
Gut Health, Prebiotics & Probiotics~855 mg10 strains + inulin, glutamine, ginger, 5 enzymes—
Cellular Electrolytes & Mineral Essentials~732 mg9 minerals—
Skin, Hair & Joint Support~315 mg4 (MSM, glucosamine, amla, biotin)~79 mg
Liver & Detox Support~315 mg4 (milk thistle, schisandra, artichoke, dandelion)~79 mg

The 995 mg botanical blend holds blue spirulina, Panax ginseng (standardised to 15% ginsenosides, which is a real specification), L-theanine, bacopa, rhodiola, grape seed, pine bark, lion's mane, cordyceps and reishi, and nine more — nineteen ingredients averaging about fifty milligrams. Standardised Panax ginseng trials use 200–400 mg; L-theanine trials use 200 mg; the lion's mane trial used 3 g.

The 969 mg Longevity Activation Blend is the one that matters most, because it is where the expensive molecules went: glycine, D-ribose, quercetin, urolithin A, apigenin, luteolin, wasabi extract, fisetin and PQQ. Note the descending order — glycine and D-ribose are listed first, and both are normally dosed in grams. Whatever is left over is split between urolithin A (trial doses 500–1,000 mg), quercetin (500–1,000 mg), fisetin and the rest.

And the 315 mg skin/joint blend puts MSM alongside glucosamine, amla and biotin — against IM8's 1,500 mg of MSM as a standalone line item, which is a genuine clinical dose. On that one ingredient, IM8 is doing something TMRW is only gesturing at.

What a trial dose actually looks like

IngredientDose that worked in trialsWhat's plausibly in the tub
Ashwagandha600 mg/day KSM-66 (Chandrasekhar et al., Indian J Psychol Med 2012;34(3):255–62, n=64, 60 days, serum cortisol −27.9%)AG1: 5:1 root extract, 19th of 21 in 7.5 g, no withanolide standardisation. IM8: inside the 200 mg complex if present at all. None at trial dose.
Rhodiola200–600 mg SHR-5, 3% rosavins (Olsson et al., Planta Med 2009, n=60, 576 mg/day)AG1: 15th of 21. IM8: in the 200 mg complex.
Spirulina1–8 g/day (Mazokopakis et al., J Sci Food Agric 2014, 4.5 g/day, n=52)AG1: 3rd of 21 in 7.5 g — likely well under 1 g. TMRW: blue spirulina, 1st of 19 in 995 mg
Chlorella1.5–10 g/dayAG1: 7th of 21 — likely under 300 mg
Beetroot~5–11 mmol nitrate ≈ 10–20 g powderAG1: 3rd of 21 in a 1.5 g complex
Rose hip5 g/day powder (Winther et al., Scand J Rheumatol 2005, n=94, osteoarthritis)AG1: 9th of 21 in 1.5 g — short by roughly two orders of magnitude
Grape seed extract150–300 mg/dayAG1: last of 21 in 1.5 g. TMRW: 8th of 19 in 995 mg
Milk thistle420 mg silymarin/dayAG1: 20th of 21 in 1.5 g. TMRW: 1st of 4 in a 315 mg blend
Cocoa flavanols500 mg flavanols/day (COSMOS, n=21,442)AG1: cocoa bean 9th of 21 in 7.5 g
Reishi1,400–5,400 mg/day extractAG1: powder, 12th of 21 in 1.5 g. IM8: in the 200 mg complex. TMRW: 16th of 19 in 995 mg
Lion's mane3 g/day, 16 weeks (Mori et al., Phytother Res 2009, n=30)TMRW: extract, 13th of 19 in a 995 mg blend. No part, no beta-glucan.
Artichoke320–1,280 mg/day (Holtmann et al., Aliment Pharmacol Ther 2003, n=247)AG1: 13th of 21. TMRW: 3rd of 4 in a 315 mg blend

Mushrooms: the question to ask

None of the three discloses whether its mushroom material is fruiting body or mycelium grown on grain, and none publishes a beta-glucan figure. That distinction is the whole ballgame. Comparative analyses submitted to the FDA (citizen petition FDA-2023-P-2340) using the Megazyme mushroom beta-glucan assay found:

SpeciesFruiting body β-glucanMycelium-on-grain β-glucanMoG α-glucan (starch)
Cordyceps34.4%<0.1%55.5–68.4%
Turkey tail57.3%6.7–9.1%24.6–44.8%
Reishi56.2%1.0–1.1%38.9–51.4%

Mycelium-on-grain averages around 6% beta-glucan against roughly 35% for fruiting bodies, and is 30–60% residual grain starch. So "reishi" on an ingredient list can legitimately describe a material that is more than half starch.

Where each one sits:

  • AG1 — shiitake and reishi, both as powder rather than extract, at positions 11 and 12 of 21 inside a 1.5 g complex. Perhaps 50–100 mg each, possibly less.
  • IM8 — reishi and chaga inside the 200 mg complex, so roughly 20 mg each. Chaga is additionally a species with no dose-response human data at all.
  • TMRW — lion's mane, cordyceps and reishi, all specified as extracts, at positions 13, 15 and 16 of nineteen inside a 995 mg blend. Cordyceps is the species where mycelium-on-grain material tests at under 0.1% beta-glucan, so "cordyceps extract" with no part declaration is the least informative entry on this page.

Ask any brand for a Megazyme beta-glucan certificate of analysis. Silence is the answer. Watch also for "polysaccharides" on a COA — hot-water-extractable polysaccharide measurement captures the starch too, which is why it is the number brands prefer to publish.

Digestive enzymes: no

For anyone with normal pancreatic function, there is no credible evidence that milligram quantities of bromelain, papain or amylase in a beverage do anything measurable. A healthy pancreas secretes hundreds of thousands of USP units per meal. Enzyme replacement therapy for actual pancreatic insufficiency is dosed at 40,000–50,000 USP lipase units per meal. AG1's bromelain sits 11th of 21 in a 7.5 g blend; IM8's four enzymes share part of 200 mg.

TMRW is the one partial exception worth crediting: its enzyme list includes lactase, which is one of only two enzymes with genuine evidence in healthy people. The other, alpha-galactosidase for legume gas, is in none of the three. But TMRW's five enzymes share part of an 855 mg blend with inulin, glutamine, ten probiotic strains and ginger, so whether there is enough lactase to matter is unknowable from the label. Brands include bromelain and papain because they are cheap and recognisable.

Prebiotics: everyone chose the safe dose

The bifidogenic threshold for inulin is around 5 g/day (Kolida et al., Eur J Clin Nutr 2007 — the lowest dose producing a significant effect in healthy adults).

ProductPrebioticVerdict
AG1Inulin, 5th of 21 in a 7.5 g complex; total label fibre 2 g, shared with apple pectin, beta-glucan, slippery elmPlausibly 1–1.5 g. Below threshold.
IM8"Prebiotics 3 g" (Pro), composition unspecifiedClosest of the three, still below
TMRWInulin inside an 855 mg blend shared with glutamine, ten probiotic strains, ginger root and five enzymesPlausibly a few hundred mg. Well below threshold.

This is a genuine dilemma rather than pure cynicism. Inulin and FOS are the F and O in FODMAP. Dose them where they work and a meaningful share of customers get bloating and cancel; dose them at a gram and you can print "with prebiotics" and nobody complains. All three chose the second option. It is a defensible commercial decision and an indefensible efficacy claim.

Worth noting the irony that IM8 markets an "85% experienced better digestion, less bloating" figure — an open-label self-reported number, not a controlled comparison.

Probiotics: strains, or the absence of them

Probiotic effects are strain-specific — that is the ISAPP consensus position (Hill et al., Nat Rev Gastroenterol Hepatol 2014), not a technicality. A species name without a strain designation tells you nothing.

AG1 Next Gen — 37 mg, 10 billion CFU, 5 strains. Lacticaseibacillus rhamnosus GG is the best-evidenced probiotic strain in existence, though almost entirely in paediatric and antibiotic-associated diarrhoea rather than in "gut health" for well adults. L. acidophilus NCFM and Bifidobacterium animalis subsp. lactis HN019 both have real strain-specific data — HN019 reduced whole-gut transit time in adults with functional constipation (Waller et al., Scand J Gastroenterol 2011, n=100). L. casei LC-11 and L. plantarum LP-115 have thin independent evidence.

Note that Next Gen dropped the UALa-01 and UABb-10 strains that were in the original formula. If you saw a claim built on those strains, it no longer applies.

**IM8 — Bacillus coagulans BC99 and Bacillus subtilis DE111, 10 billion CFU combined.** Spore-formers are the honest engineering choice for a shelf-stable powder: they survive ambient storage and gastric acid in a way lactobacilli do not. DE111 has real human data, including demonstrated germination in the human small intestine (Freedman et al., Front Microbiol 2021).

TMRW — 10 strains, 10 billion CFU. L. rhamnosus, L. plantarum, L. acidophilus, L. casei, L. paracasei, B. lactis, B. longum, B. breve, S. thermophilus and B. subtilis — all ten named at species level only, with no strain designation at all. Since probiotic effects are strain-specific, that list tells you nothing verifiable: L. rhamnosus GG has hundreds of trials behind it and another L. rhamnosus strain may have none, and the label does not say which you are getting. Ten billion CFU split ten ways is also one billion per organism, below the effective dose in most of the underlying single-strain trials.

Two questions worth asking any brand. First: is the CFU count at time of manufacture or guaranteed through expiry? US law does not require you to say, and industry convention is to overage 50–100% at manufacture. None of these three discloses which basis it uses. Second: how is it counted? AG1 has published on using digital PCR — but dPCR counts DNA, including from dead cells, unless a viability dye step is included.

A related point: ascorbic acid is a pro-oxidant in the presence of transition metals. AG1 puts 500 mg of vitamin C alongside iron, copper, manganese and zinc in the same 13 grams, next to hygroscopic ingredients like inulin and fruit powders that raise water activity every time you open the pouch. Spore-formers shrug that off. Lactobacilli do not.


Where they genuinely diverge: TMRW's longevity actives

This is TMRW's whole pitch and the reason it costs what it does. It is also where the dose gap is widest — with two honourable exceptions.

CompoundTMRW doseTrial doseVerdict
Taurine1,200 mg1,000–6,000 mgIn range. One of two defensible doses on the label.
NMN500 mg250–1,000 mgIn range, but human outcomes are biomarker-level only
Ca-AKG~1,000 mgDose-matched to an uncontrolled, sponsor-owned studyDose fine, evidence base weak
Spermidine5 mgAbove the trial dose — but the 12-month SmartAge RCT (n=100) was null5 mg is also under half normal dietary intake (~7–15 mg/day)
Pterostilbene50 mg100 mg in the one safety trialSee safety note below
TMG (betaine)250 mg1,500–6,000 mg6–24× short
Acetyl-L-carnitine750 mg1,500–3,000 mg, with demonstrated dose-response2–4× short
Glutathione (oral)300 mg300 mg sits at the arm that failed; 1,000 mg was the arm that workedDosed at the null
Urolithin Ain a 969 mg blend of 9, behind glycine and D-ribose500–1,000 mgPlausibly 1:100–200
Fisetinin the 969 mg blend, listed 8th of 920 mg/kg for 2 days per month — a different paradigm entirelyDaily micro-dosing is not what the trials did
Quercetinin the 969 mg blend500–1,000 mgPlausibly ~1:100

The pattern is the finding, and the panel now proves it. Every compound TMRW quantifies on its own line is one where the number holds up or is at least arguable — taurine, NMN, Ca-AKG, CoQ10, acetyl-L-carnitine, ALA, choline. Every compound where the trial dose runs 500–1,000 mg — urolithin A, quercetin, fisetin, apigenin, PQQ — is inside the 969 mg blend, sharing it with glycine and D-ribose, which are themselves listed first and normally dosed in grams. Non-disclosure is not random. It tracks the gap between the trial dose and what is actually in the tub.

The same logic explains the mineral blend. Potassium, magnesium, sodium, zinc and chromium get their own lines; calcium, copper, iodine, selenium, manganese and boron are pooled into 732 mg. The ones on their own lines are the ones whose numbers are presentable.

One safety note that deserves its own line. Pterostilbene at 100 mg/day raised LDL cholesterol by roughly 17 mg/dL (p≈0.001) in Riche et al., Journal of Toxicology 2014;2014:463595, n=80. TMRW's 50 mg is half that dose, and this is a single trial, but it is the opposite of what a heart-health-framed supplement is supposed to do, and it is worth knowing if you are tracking your lipids.

Two things worth knowing on the NMN side. The TGA added NMN to the Permissible Ingredients Determination on 10 December 2025, making Australia the first country to formally permit it in listed medicines; the FDA reversed its own NMN exclusion on 29 September 2025. And the taurine story has weakened: a 2025 Science paper using longitudinal data failed to replicate the age-related decline in circulating taurine that the widely-publicised 2023 Singh et al. paper was built on.


Heavy metals, certification, and the gap between them

This is the most concrete, verifiable finding on this page, and it applies to the whole category.

All three brands carry NSF Certified for Sport. That certification screens for 290+ banned substances, verifies label accuracy, and confirms GMP compliance. It does not assess whether the product works, whether doses are efficacious, or whether ingredient amounts are meaningful. And its heavy-metal ceiling — 10 µg lead per day under NSF/ANSI 173 — is twenty times more permissive than California's Proposition 65 threshold of 0.5 µg/day.

Which means a product can be NSF Certified for Sport and simultaneously require a Prop 65 lead warning. AG1 is exactly that product. It carries the warning. AG1's position is that every batch tests below USP and NSF limits, which is true and entirely compatible with exceeding the much stricter Prop 65 threshold.

ConsumerLab bought and tested AG1 in 2022 and did not pass it, publishing the conclusion that because of the lead per serving found, regular use should be avoided by children and women who may be pregnant. Exact figures sit behind their paywall.

The category-wide picture is worse. Thirty-seven best-selling greens and spirulina powders were tested July–November 2024 by Eurofins and Alkemist Labs (both ISO-certified, ICP-MS via AOAC methods). Ten greens powders exceeded Prop 65 lead limits, including eight of the thirteen organic ones; excesses ran 1.5× to 9.2×; and ten of twelve mixed-greens brands carried no Prop 65 warning despite exceeding the threshold. One caveat you should weigh: the testing was commissioned by Cyanotech Corporation, a spirulina producer and therefore an interested party. Brands were not named, and AG1 was not among those tested.

This is not surprising once you think about it. Lead and cadmium accumulate in plant tissue from soil. A product built from concentrated plant material — and organic farming does not change soil metal content — concentrates whatever the plants took up. It is the structural risk of the format.

Neither IM8 nor TMRW has any independent lab testing in the public record. Every quality claim for both is currently the company's own. That is not an accusation; it is an absence of evidence, and it cuts both ways.

Regulators are moving on powdered supplements generally: the Texas Attorney General has opened an industry-wide investigation into protein powder manufacturers over lead and cadmium, following Consumer Reports testing that found high lead levels.


What buyers actually report

A note on sourcing: we could not access Reddit from our research environment, so nothing below is paraphrased from threads we did not read. What follows is from complaint records, a filed lawsuit, and named critics.

Subscription friction is AG1's most consistent complaint, and it is now litigated. The BBB file shows 80+ closed complaints over three years, with roughly 60–70% concerning subscriptions and billing — charges after stated cancellation, shipments arriving post-cancellation. Cancellation historically required a phone call or live chat; an online option was added in late 2023, and 2024 complaints still cite friction.

In February 2026, Hoke v. AG1 (USA), Inc. (No. 2:26-cv-01110, C.D. Cal., filed 3 February 2026) alleged that AG1 surreptitiously enrols customers in auto-renewing subscriptions, with only a minimal "every 30 days" disclosure at checkout, no affirmative-consent checkbox, auto-renewal terms omitted from confirmation emails, and no easy cancellation path — claims under California's Automatic Renewal Law, the UCL, CLRA and False Advertising Law. It is an allegation, not a finding. But it corroborates the complaint pattern independently.

Bloating has a mechanism, not just anecdotes. AG1 contains inulin. Inulin is a fermentable oligosaccharide. In people with IBS or FODMAP sensitivity, that reliably produces gas and bloating. You do not need user reports to predict it.

IM8 and TMRW have no usable user sentiment corpus. IM8 launched in November 2024 and TMRW on 22 September 2026 — about a week before this page was written. Essentially everything currently online reviewing either product is affiliate content.

What the named experts say. Harvard's JoAnn Manson on the weak rigour of the small trials; McGill's Jonathan Jarry on there being very little scientific support; UC Irvine's Mahtab Jafari, quoted in the Boston Globe: the marketing is well ahead of the actual science. Dietitian Maddie Pasquariello's point is the most useful one for a buyer — proprietary blends hide whether doses are subtherapeutic or excessive, and you cannot tell which.

Two pieces of company background worth knowing. AG1 founder Chris Ashenden resigned in October 2024 after his 2011 New Zealand criminal convictions for a housing scam became public; Kat Cole became CEO. And the AG1 formula changed more than fifty times between 2010 and 2024, which puts some perspective on "Next Gen" being described as the brand's most significant innovation yet.

On the science AG1 does fund: a 2026 Frontiers in Nutrition RCT found more micronutrient requirements met versus placebo and good tolerability — in 20 resistance-trained adults over 14 days, funded by AG1, with several authors employed by the manufacturer. That is a tolerability study, not a health-outcome result.


The price arithmetic

Monthly subscriptionBest rateOne-off
AG1A$4.97/servingA$3.66/serving (quarterly)—
IM8~US$2.97/serving (~A$4.50)~US$1.96/serving (~A$3.00, quarterly)US$112
TMRWA$4.30/servingA$3.98/serving (60/90-day)A$5.73/serving

AG1's Australian prices exclude tax and shipping, charged at checkout. IM8 advertises free shipping to the UK, US, Canada and EU — Australia is not on that list, and IM8 figures above are converted from USD, not quoted in AUD. TMRW ships free to Australia and quotes in AUD natively.

At roughly A$3.66–4.97 a serving, you are spending A$110–150 a month. For comparison, a good multivitamin, vitamin D, magnesium glycinate at a real 300 mg dose, creatine and fish oil — all at trial doses rather than trace amounts — runs well under half that in Australia. What you are buying with the difference is one scoop instead of five bottles, plus the ingredients that only come in this format.

Whether that is worth it is a real question with a real answer, and the answer depends on whether you would otherwise take nothing at all. A greens powder you actually drink beats a cupboard of supplements you don't.


The verdict

If you want one tub to function as a multivitamin: IM8 Pro. It is the only one of the three with a coherent mineral profile — iodine at the RDI, selenium at the RDI, a sane zinc-to-copper ratio, 2000 IU of vitamin D, 100 mg of magnesium. It also has the best-engineered probiotic choice (spore-formers in a shelf-stable powder) and two genuinely clinical doses in MSM and CoQ10. Against it: preformed vitamin A at 900 mcg daily, a 200 mg complex doing a lot of marketing work, no independent testing in the public record, and no Australian storefront.

If you want the specific longevity actives and can afford them: TMRW, with your eyes open. Taurine at 1,200 mg, NMN at 500 mg, CoQ10 at 150 mg, acetyl-L-carnitine at 750 mg and ALA at 100 mg are all real, disclosed doses, and no other product here carries most of them at all. Its zinc is the best-judged of the three and its vitamin A is the safer form. Against it: thiamin at twelve times the RDI for no reason, riboflavin below the RDI, no niacin in a product built on NAD+, magnesium at 24 mg, six proprietary blends on a label that markets "no proprietary blends", and every 500-milligram-class molecule — urolithin A, quercetin, fisetin — hidden inside a 969 mg blend behind two gram-dosed amino acids. The product has existed for a week and there is no independent testing of it whatsoever.

AG1 is the most established, the most transparent about which ingredients it contains, and the one with the longest paper trail — some of which is unflattering. Its two real problems are structural: no vitamin D and no iodine in a product sold as foundational daily nutrition, and a 100:1 zinc-to-copper ratio at 250% of the female zinc RDI. It is also the only one of the three that has been independently tested and carries a lead warning — though it is worth being fair about the asymmetry there: AG1 has been tested and the others have not, which is not the same as AG1 being worse.

And the thing none of them will tell you: if you are going to take one of these, take it away from meals you are relying on for iron. The polyphenol-iron interaction is the best-evidenced downside of the format and the least discussed. Black tea cut non-haem iron absorption by 79–94% and cocoa by 71% in Hurrell, Reddy & Cook (Br J Nutr 1999;81:289–95), with beverages supplying 100–400 mg of total polyphenols reducing absorption by 60–90%. AG1 Next Gen added cocoa extract and rutin on top of an existing green tea, berry and botanical matrix. None of these products contains meaningful iron to compensate. For menstruating Australian women — RDI 18 mg, the group most likely to be iron-marginal — that is the most concrete real-world downside on this page.

Take it between meals, or at least an hour away from your main source of plant iron.


Frequently asked

Is AG1 or IM8 better? IM8 Pro has the more complete micronutrient profile — it includes vitamin D and iodine, which AG1 omits entirely, and pairs its zinc with adequate copper. AG1 is more transparent about its full ingredient list and has a longer independent track record, including a Prop 65 lead warning that IM8 has simply never been tested for. For pure nutritional coverage, IM8 Pro. For a known quantity, AG1.

Is TMRW worth it compared to AG1? TMRW costs roughly the same and does a different job. It carries real, disclosed doses of taurine (1,200 mg), NMN (500 mg), acetyl-L-carnitine (750 mg) and CoQ10 (150 mg) that AG1 does not carry at all. Its weakness is the other half of the label: riboflavin below the RDI, no niacin, 24 mg of magnesium, and six category blends covering roughly 4.3 g of a 10.3 g scoop. If the longevity actives are what you want, TMRW is the only one of the three offering them at meaningful doses. If you want a daily multivitamin, IM8 Pro is the better buy.

Do greens powders replace vegetables? No, and none of these brands claims they do. A 13 gram scoop cannot supply the fibre, water, volume or food matrix of a plate of vegetables. The plant material in AG1's phytonutrient complex totals 1.5 grams — roughly one-hundredth of a serve of broccoli by weight.

Why do they use proprietary blends? Because they may. US regulation (21 CFR 101.36) requires blend ingredients to be listed in descending order by weight and requires only the blend's total weight; individual amounts may be omitted. Nothing prevents full disclosure. AG1's own label proves this — it declares CoQ10, alpha-lipoic acid, benfotiamine, myo-inositol and boron individually with exact quantities. Around thirty ingredients are fully disclosed. Only the forty-two whose doses would look small are pooled.

Australia is different again: a product entering as a food discloses ingredients in descending order with no quantities at all, while one listed as a complementary medicine (AUST L) must declare the name and quantity of each active ingredient on the label.

Does NSF Certified for Sport mean it's clean? It means it has been screened for banned substances and that the label is accurate. It does not assess efficacy, dosing, or whether anything works — and its lead ceiling is twenty times more permissive than California's Prop 65 threshold. All three brands hold it, so it does not distinguish between them.

Is the vitamin B6 in these a problem in Australia? Not from these products alone. AG1 and IM8 supply 5 mg and TMRW 2.5 mg, all well under the 10 mg threshold that triggers Australia's mandatory warning statement. The risk is stacking several B6-containing supplements, none of which individually needs a warning.


Last reviewed 1 October 2026. Doses are taken from the manufacturers' published supplement facts panels. TMRW's panel was read from the "View Supplement Facts" display on its Australian product page on 1 October 2026; blend totals are given there as approximate ("~") figures and are reproduced as published. This page is general information, not medical advice.